These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17186852)

  • 1. Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing cats.
    McEntee MC; Rassnick KM; Bailey DB; Balkman CE; Flanagan JL; Beaulieu BB; Zgola MM; Lewis LD; Page RL
    J Vet Intern Med; 2006; 20(6):1370-5. PubMed ID: 17186852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing dogs.
    McEntee MC; Rassnick KM; Lewis LD; Zgola MM; Beaulieu BB; Balkman CE; Page RL
    Am J Vet Res; 2006 Jun; 67(6):1057-62. PubMed ID: 16740102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxel.
    Malingré MM; Ten Bokkel Huinink WW; Mackay M; Schellens JH; Beijnen JH
    Eur J Clin Pharmacol; 2001 Jul; 57(4):305-7. PubMed ID: 11549208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of docetaxel to cats with cancer.
    Shiu KB; McCartan L; Kubicek L; Vail DM
    J Vet Intern Med; 2011; 25(4):916-9. PubMed ID: 21615496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.
    Waite A; Balkman C; Bailey D; Kiselow M; Flory A; Beaulieu BB; Lewis LD; McEntee M
    Vet Comp Oncol; 2014 Jun; 12(2):160-8. PubMed ID: 22905693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
    Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
    J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats.
    McEntee M; Silverman JA; Rassnick K; Zgola M; Chan AO; Tau PT; Page RL
    Vet Comp Oncol; 2003 Jun; 1(2):105-12. PubMed ID: 19379322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors.
    Bailey DB; Rassnick KM; Dykes NL; Pendyala L
    Am J Vet Res; 2009 Jun; 70(6):770-6. PubMed ID: 19496668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interaction.
    Motonaga M; Yamamoto N; Makino Y; Ando-Makihara R; Ohe Y; Takano M; Hayashi Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):713-21. PubMed ID: 26233803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats.
    Lachowicz JL; Post GS; Brodsky E
    J Vet Intern Med; 2005; 19(6):860-4. PubMed ID: 16355681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer.
    Tolcher AW; Kuhn J; Schwartz G; Patnaik A; Hammond LA; Thompson I; Fingert H; Bushnell D; Malik S; Kreisberg J; Izbicka E; Smetzer L; Rowinsky EK
    Clin Cancer Res; 2004 Aug; 10(15):5048-57. PubMed ID: 15297406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
    Chambers SK; Davis CA; Chambers JT; Schwartz PE; Lorber MI; Hschumacher RE
    Clin Cancer Res; 1996 Oct; 2(10):1699-704. PubMed ID: 9816119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial and pharmacokinetic analysis of ifosfamide in cats with sarcomas.
    Rassnick KM; Moore AS; Northrup NC; Kristal O; Beaulieu BB; Lewis LD; Page RL
    Am J Vet Res; 2006 Mar; 67(3):510-6. PubMed ID: 16506919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors.
    Garland LL; Hidalgo M; Mendelson DS; Ryan DP; Arun BK; Lovalvo JL; Eiseman IA; Olson SC; Lenehan PF; Eder JP
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4274-82. PubMed ID: 16857802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.
    Fakih MG; Creaven PJ; Ramnath N; Trump D; Javle M; Strychor S; Repinski TV; Zamboni BA; Schwarz JK; French RA; Zamboni WC
    Clin Cancer Res; 2005 Aug; 11(16):5942-9. PubMed ID: 16115937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of docetaxel and topotecan in patients with advanced malignancies.
    Dubey S; Hutson P; Alberti D; Arzoomanian R; Binger K; Volkman J; Feierabend C; Wilding G; Schiller JH
    J Oncol Pharm Pract; 2005 Dec; 11(4):131-8. PubMed ID: 16595064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.
    Malingré MM; Richel DJ; Beijnen JH; Rosing H; Koopman FJ; Ten Bokkel Huinink WW; Schot ME; Schellens JH
    J Clin Oncol; 2001 Feb; 19(4):1160-6. PubMed ID: 11181682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
    Moore AS; Ruslander D; Cotter SM; Rand WM; L'Heureux DA
    J Am Vet Med Assoc; 1995 May; 206(10):1550-4. PubMed ID: 7775231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.